Showing results (1-10 of 52) with videos related to

Sort By:
Pageof 6
Reumatologia Clinica|July 29, 2011
[Inflammatory myopathies. New concepts]Francisco Javier López Longo
Medicina Clinica|December 1, 2014
[Modulating the survival and maturation system of B lymphocytes: Current and future new therapeutic strategies in systemic lupus erythematosus]Lara Valor, Francisco Javier López-Longo
Drug News & Perspectives|January 15, 2010
The value of anti-cyclic citrullinated peptide antibodies in rheumatoid arthritis: do they imply new risk factors?Francisco Javier López-Longo, Silvia Sánchez-Ramón, Luis Carreño
Reumatologia Clinica|July 29, 2011
[Interleukins network in rheumatoid arthritis pathophysiology: beyond proinflammatory cytokines]Silvia Sánchez-Ramón, Francisco Javier López-Longo, Luis Carreño
Paediatric Drugs|April 19, 2002
Treatment options for juvenile-onset systemic lupus erythematosusLuis Carreño, Francisco Javier López-Longo, Carlos Manuel González, et al.
Rheumatology International|January 26, 2018
Variability in the prescription of biological drugs in rheumatoid arthritis in Spain: a multilevel analysisFrancisco Javier López-Longo, Daniel Seoane-Mato, María A Martín-Martínez, et al.
The Journal of Rheumatology|October 11, 2002
Anti-Sa sera from patients with rheumatoid arthritis contain at least 2 different subpopulations of anti-Sa antibodiesMilagrosa Escalona, Francisco Javier López-Longo, Carlos Manuel González, et al.
Clinical and Experimental Rheumatology|May 29, 2013
Idiopathic recurrent pericarditis treated successfully with tumour necrosis factor alpha blocking agents (anti-TNF-α)Juan Carlos Nieto González, Indalecio Monteagudo Saez, Francisco Javier López-Longo, et al.
The Journal of Rheumatology|August 2, 2006
Anti-cyclic citrullinated peptide versus anti-Sa antibodies in diagnosis of rheumatoid arthritis in an outpatient clinic for connective tissue disease and spondyloarthritisFrancisco-Javier López-Longo, Margarita Rodríguez-Mahou, Silvia Sánchez-Ramón, et al.
Rheumatology International|June 20, 2018
Identifying markers of sustained remission in rheumatoid arthritis patients on long-term tapered biological disease-modifying antirheumatic drugsLara Valor, Jesús Garrido, Lina Martínez-Estupiñán, et al.
Pageof 6